Dr. Jack Kavanaugh

Jack Kavanaugh is respected doctor and a business executive in science technology companies. He holds D.D.S., M.B.A. and B.A. degrees from UCLA, and M.D. from U.S.C.  From beginning he was highly successful dentist. A major skiing accident prevents him practicing dentistry again. After the accident he went on to earn M.B.A from U.C.L.A. He completed his residency in ophthalmology at UCLA’s Jules Stein Institute, where he later taught surgery as a part-time visiting professor.

Dr Jack Kavanaugh ’s business accomplishments: As CEO and Chairman of ZetaRx Biosciences, Inc, he successfully combined the intellectual property from three globally-recognized health care and research institutions, assembled a highly respected management team, and lead the development of the FDA clinical trial strategy.                                                             In late 2013, ZetaRx was sold, becoming the core of Juno Therapeutics, which went on to have the largest biotech IPO of 2014, attaining a market cap of approximately $6 billion. Recently, Juno reported 91% clinical trial complete remission of terminal cancer patients treated with their immunotherapy.

As an ophthalmologist and entrepreneur, Dr. Jack Kavanaugh has been involved with the creation and management of several groundbreaking biotechnology firms, including Calhoun Vision, Inc. As a member and Chairman of the Board of Directors. Dr. Jack Kavanaugh served as Chairman and Chief Executive Officer of Amerident, a 12-clinic organization of family dentistry offices he formed in the 1990s. Amerident earned numerous accolades and awards under Dr. Jack Kavanaugh’s leadership and provided much-needed care to young patients from underserved communities throughout the state of Nevada. Participating in an extensive variety of philanthropic projects aside from the aforementioned professional pursuits. Dr. Jack Kavanaugh strives to benefit the community through various civic endeavors.

Jack Kavanaugh began his distinctive career as a highly successful dentist. A major skiing accident in which he broke his neck and shattered his leg, prevented him from practicing dentistry again. From this turning point, Kavanaugh went on to earn his M.B.A. from U.C.L.A., then worked in mergers and acquisitions with a former partner who had been managing director / senior partner at McKenzie International. In 1984, they formed International Strategy Consulting Group a management and M.B.A. consulting firm. In the late ‘80’s. Dr. Jack Kavanaugh brought Tech Team, later known as Team Global, public. The share price rose from an initial investor price of 11 cents to approximately $27 per share. He continued in private equity and in 2000 held the first board meeting of Calhoun Vision, Inc. a biotechnology firm that developed the world’s first and only light adjustable intraocular lens for cataract surgery, at his home. He served as a board member from 2000 and then served as Chair...